Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Clinical Imbalances

Hormonal

Structural Integrity and Musculoskeletal

Modifiable Lifestyle Factors

Diet

Laboratory Testing

Blood

Imaging

Text Availability

Abstract

403

Full text

307

Free full text

174

Publication Types

Journal Article

405

Randomized Controlled Trial

239

Research Support, Non-U.S. Gov't

210

Multicenter Study

107

Comparative Study

Review

Clinical Trial

Research Support, N.I.H., Extramural

Clinical Trial, Phase II

Meta-Analysis

Clinical Trial, Phase III

Clinical Trial, Phase I

Systematic Review

Observational Study

Comment

Letter

Research Support, U.S. Gov't, P.H.S.

Research Support, U.S. Gov't, Non-P.H.S.

Evaluation Study

Research Support, N.I.H., Intramural

Controlled Clinical Trial

Editorial

Validation Study

Consensus Development Conference

Clinical Trial, Phase IV

Network Meta-Analysis

Pragmatic Clinical Trial

Publication Year

From

Quick links

Individual year

2026

2025

2024

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Endpoint Determination""[mesh_terms]

416 Results

Searching titles within these results

Rationale and design of the treatment of hyponatremia based on lixivaptan in NYHA class III/IV cardiac patient evaluation (THE BALANCE) study.

William T Abraham, Juan M Aranda, John P Boehmer, Uri Elkayam, Edward M Gilbert, Stephen S Gottlieb, Gerd Hasenfuss, Marrick Kukin, Brian D Lowes, John B O'Connell, Luigi Tavazzi, Arthur M Feldman, Barry Ticho, Cesare Orlandi

Clinical and translational science 2011;3(5):249-53

Free Full Text

Abstract

Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoints Series.

James McDonald, Mark Stares, Judith Sayers, Tora S Solheim, Melanie Simpson, Ester Kristine Størkson, Michael S Yule, Christine Greil, Barry J A Laird, Stein Kaasa, Richard J E Skipworth, Leo R Brown, Asta Bye, Mariana S Sousa, Trude R Balstad, Gunnhild Jakobsen, Inger Ottestad, Jann Arends, Ola Magne Vagnildhaug, Iain Philips, Marianne Hjermstad, Ross Dolan, Olav Dajani

Journal of cachexia, sarcopenia and muscle 2025;16(2):e13756

Free Full Text

Abstract

The promise and pitfalls of composite endpoints in sepsis and COVID-19 clinical trials.

P M Brown, Tormod Rogne, Erik Solligård

Pharmaceutical statistics 2021;20(2):413-417

Full Text

Abstract

Therapeutic approaches to achieve desired blood pressure goals: focus on calcium channel blockers.

G L Bakris, S Koshy

Cardiovascular drugs and therapy 2001;14(3):295-301

Full Text

Abstract

The role of statins for the primary and secondary prevention of coronary heart disease in women.

Anna I Kakafika, Vasilios G Athyros, Dimitri P Mikhailidis, Asterios Karagiannis, Konstantinos Tziomalos

Current pharmaceutical design 2009;15(10):1054-62

Full Text

Abstract

Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial.

Borge G Nordestgaard, John J P Kastelein, Kevin C Maki, Andrey Susekov, Marat Ezhov, Ben N Machielse, Douglas Kling, Michael H Davidson

Journal of clinical lipidology 2014;8(1):94-106

Full Text

Abstract

Future Directions in Eosinophilic Esophagitis.

Ikuo Hirano

Gastrointestinal endoscopy clinics of North America 2018;28(1):111-122

Full Text

Abstract

GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trials.

Lesley A Inker, Hiddo J Lambers Heerspink, Hasi Mondal, Christopher H Schmid, Hocine Tighiouart, Farzad Noubary, Josef Coresh, Tom Greene, Andrew S Levey

American journal of kidney diseases : the official journal of the National Kidney Foundation 2015;64(6):848-59

Full Text

Abstract

Specific prebiotics in a formula for infants with Phenylketonuria.

Anita MacDonald, Barbara Cochrane, Harm Wopereis, Nik Loveridge

Molecular genetics and metabolism 2012;104 Suppl():S55-9

Full Text

Abstract

Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial.

Alan C Yeung, Ron Waksman, Albert E Raizner, Lynn Vandertie, Alexandra J Lansky

Lancet (London, England) 2002;359(9306):551-7

Full Text

Abstract

A pragmatic approach to intravenous anaesthetics and electroencephalographic endpoints for the treatment of refractory and super-refractory status epilepticus in critical care.

Arjune Sen, Christopher Kearns, Karina Fitzgibbon, Simon Raby, Claire Hallett, Olivia Moswela, Sidra Aurangzeb, Mario Ganau, Lara Prisco

Seizure 2020;75():153-164

Free Full Text

Abstract

Did the antioxidant trials fail to validate the oxidation hypothesis?

S Parthasarathy, N Khan-Merchant, M Penumetcha, B V Khan, N Santanam

Current atherosclerosis reports 2001;3(5):392-8

Full Text

Abstract

Studying coronary plaque regression with IVUS: a critical review of recent studies.

Kaoru Tanaka, Stephane G Carlier

Journal of interventional cardiology 2006;19(1):11-5

Free Full Text

Clinical significance of apolipoprotein A5.

E Shyong Tai, Jose M Ordovas

Current opinion in lipidology 2008;19(4):349-54

Free Full Text

Abstract

Nutrition in Menopausal Women: A Narrative Review.

Thais R Silva, Poli Mara Spritzer, Fernando M Reis, Karen Oppermann

Nutrients 2021;13(7):2149

Plain Language Summary

Free Full Text

Abstract

Results: 1 – 15 / 416

Filters

Expert Opinion

Clinical Imbalances

Modifiable Lifestyle Factors

Laboratory Testing

Text Availability

Publication Types

Publication Year

Results for ""Endpoint Determination""[mesh_terms]

Rationale and design of the treatment of hyponatremia based on lixivaptan in NYHA class III/IV cardiac patient evaluation (THE BALANCE) study.

Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoints Series.

The promise and pitfalls of composite endpoints in sepsis and COVID-19 clinical trials.

Therapeutic approaches to achieve desired blood pressure goals: focus on calcium channel blockers.

The role of statins for the primary and secondary prevention of coronary heart disease in women.

Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial.

Future Directions in Eosinophilic Esophagitis.

GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trials.

Specific prebiotics in a formula for infants with Phenylketonuria.

Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial.

A pragmatic approach to intravenous anaesthetics and electroencephalographic endpoints for the treatment of refractory and super-refractory status epilepticus in critical care.

Did the antioxidant trials fail to validate the oxidation hypothesis?

Studying coronary plaque regression with IVUS: a critical review of recent studies.

Clinical significance of apolipoprotein A5.

Nutrition in Menopausal Women: A Narrative Review.

Results for
""Endpoint Determination""[mesh_terms]